• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Newron - Articles and news items

safinamide

Parkinson’s disease therapy safinamide launches in the UK

Industry news / 23 May 2016 / Victoria White, Digital Content Producer

Commenting on the launch, Maurizio Castorina, CEO of Zambon, said safinamide offers PD patients “a novel therapeutic option”…

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Industry news / 18 May 2016 / Mandy Parrett, Editorial Assistant

Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +